Frontotemporal dementia mutant tau (P301L) locks Fyn in an open, active conformation conducive to nanoclustering

Fyn is a Src kinase that controls critical signalling cascades and its postsynaptic enrichment underpins synaptotoxicity in Alzheimer’s disease (AD) and frontotemporal dementia (FTLD-tau). Previously, we found that pathogenic FTLD tau mutant (P301L) expression promotes aberrant trapping of Fyn in nanoclusters within hippocampal dendrites via an unknown mechanism (Padmanabhan et al., 2019). Here, we imaged Fyn-mEos2 using single particle tracking photoactivated localization microscopy (sptPALM) to demonstrate that nanoclustering of Fyn in hippocampal dendrites is promoted by Fyn’s open, primed conformation. Disrupting the auto-inhibitory, closed conformation of Fyn through phospho-inhibition, and perturbation of Fyn’s SH3 domain increases, Fyn’s nanoscale trapping. However, inhibition of Fyn’s catalytic domain has no impact on its mobility. Tau-P301L promotes Fyn lateral trapping via Fyn opening and ensuing increased catalytic activation. Pathogenic tau may therefore drive synaptotoxicity by locking Fyn in an open, catalytically active conformation, leading to postsynaptic entrapment and aberrant signalling cascades.

[1]  J. Götz,et al.  Fyn Kinase Controls Tau Aggregation In Vivo. , 2020, Cell reports.

[2]  T. Golde,et al.  Fyn depletion ameliorates tauP301L-induced neuropathology , 2020, Acta Neuropathologica Communications.

[3]  S. Strittmatter,et al.  Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy , 2020, Acta Neuropathologica Communications.

[4]  P. Verstreken,et al.  Need for speed: Super-resolving the dynamic nanoclustering of syntaxin-1 at exocytic fusion sites , 2020, Neuropharmacology.

[5]  J. Sibarita,et al.  Real-time nanoscale organization of amyloid precursor protein. , 2020, Nanoscale.

[6]  Jonathan R Roth,et al.  A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity , 2019, Neurobiology of Disease.

[7]  Dongxue Wang,et al.  Systematic profiling of SH3-mediated Tau-Partner interaction network in Alzheimer's disease by integrating in silico analysis and in vitro assay. , 2019, Journal of molecular graphics & modelling.

[8]  Ramón Martínez-Mármol,et al.  Frontotemporal dementia mutant Tau promotes aberrant Fyn nanoclustering in hippocampal dendritic spines , 2019, eLife.

[9]  Nicolas L. Fawzi,et al.  The SH3 domain of Fyn kinase interacts with and induces liquid–liquid phase separation of the low-complexity domain of hnRNPA2 , 2018, The Journal of Biological Chemistry.

[10]  J. Attems,et al.  Phosphorylation of different tau sites during progression of Alzheimer’s disease , 2018, Acta Neuropathologica Communications.

[11]  Martin Hruska,et al.  Synaptic nanomodules underlie the organization and plasticity of spine synapses , 2018, Nature Neuroscience.

[12]  E. Mandelkow,et al.  Multivalent cross-linking of actin filaments and microtubules through the microtubule-associated protein Tau , 2017, Nature Communications.

[13]  G. Goodhill,et al.  Visualizing endocytic recycling and trafficking in live neurons by subdiffractional tracking of internalized molecules , 2017, Nature Protocols.

[14]  J. Götz,et al.  Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn‐mediated local protein translation , 2017, The EMBO journal.

[15]  Antoine Triller,et al.  Physico-Pathologic Mechanisms Involved in Neurodegeneration: Misfolded Protein-Plasma Membrane Interactions , 2017, Neuron.

[16]  L. Mao,et al.  An Essential Role of Fyn in the Modulation of Metabotropic Glutamate Receptor 1 in Neurons , 2017, eNeuro.

[17]  K. Vossel,et al.  Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture , 2017, Molecular Neurodegeneration.

[18]  Rosemary J. Jackson,et al.  Tau association with synaptic vesicles causes presynaptic dysfunction , 2017, Nature Communications.

[19]  O. Hantschel,et al.  Selective Targeting of SH2 Domain–Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies , 2017, Journal of molecular biology.

[20]  Geoffrey J. Goodhill,et al.  In vivo single-molecule imaging of syntaxin1A reveals polyphosphoinositide- and activity-dependent trapping in presynaptic nanoclusters , 2016, Nature Communications.

[21]  T. Lenaerts,et al.  Dynamically Coupled Residues within the SH2 Domain of FYN Are Key to Unlocking Its Activity. , 2016, Structure.

[22]  E. Hosy,et al.  The Munc18-1 domain 3a hinge-loop controls syntaxin-1A nanodomain assembly and engagement with the SNARE complex during secretory vesicle priming , 2016, The Journal of cell biology.

[23]  Y. Gambin,et al.  Munc18-1 is a molecular chaperone for α-synuclein, controlling its self-replicating aggregation , 2016, The Journal of cell biology.

[24]  W. Noble,et al.  Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease , 2016, Acta neuropathologica communications.

[25]  S. Raghavachari,et al.  Protein Crowding within the Postsynaptic Density Can Impede the Escape of Membrane Proteins , 2016, The Journal of Neuroscience.

[26]  G. Besra,et al.  The actin cytoskeleton modulates the activation of iNKT cells by segregating CD1d nanoclusters on antigen-presenting cells , 2016, Proceedings of the National Academy of Sciences.

[27]  B. Kay,et al.  Directed Evolution of a Highly Specific FN3 Monobody to the SH3 Domain of Human Lyn Tyrosine Kinase , 2016, PloS one.

[28]  Brendan Santyr,et al.  Activity-regulated trafficking of the palmitoyl-acyl transferase DHHC5 , 2015, Nature Communications.

[29]  S. Strittmatter,et al.  Fyn inhibition rescues established memory and synapse loss in Alzheimer mice , 2015, Annals of neurology.

[30]  L. Blanchoin,et al.  Tau co-organizes dynamic microtubule and actin networks , 2015, Scientific Reports.

[31]  D. Xia,et al.  Pseudophosphorylation of Tau at distinct epitopes or the presence of the P301L mutation targets the microtubule-associated protein Tau to dendritic spines. , 2015, Biochimica et biophysica acta.

[32]  Daniel Choquet,et al.  Glutamate-Induced AMPA Receptor Desensitization Increases Their Mobility and Modulates Short-Term Plasticity through Unbinding from Stargazin , 2015, Neuron.

[33]  R. Bostwick,et al.  AlphaScreen HTS and Live-Cell Bioluminescence Resonance Energy Transfer (BRET) Assays for Identification of Tau–Fyn SH3 Interaction Inhibitors for Alzheimer Disease , 2014, Journal of biomolecular screening.

[34]  T. Smithgall,et al.  Differential Sensitivity of Src-Family Kinases to Activation by SH3 Domain Displacement , 2014, PloS one.

[35]  D. Xia,et al.  Premature lethality, hyperactivity, and aberrant phosphorylation in transgenic mice expressing a constitutively active form of Fyn , 2014, Front. Mol. Neurosci..

[36]  A. Buisson,et al.  Activity-Dependent Tau Protein Translocation to Excitatory Synapse Is Disrupted by Exposure to Amyloid-Beta Oligomers , 2014, The Journal of Neuroscience.

[37]  R. Huganir,et al.  Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer‐induced AMPA glutamate receptor signaling deficits , 2014, The European journal of neuroscience.

[38]  M. Goedert,et al.  Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice , 2013, Acta neuropathologica communications.

[39]  Daniel Choquet,et al.  Super-Resolution Imaging Reveals That AMPA Receptors Inside Synapses Are Dynamically Organized in Nanodomains Regulated by PSD95 , 2013, The Journal of Neuroscience.

[40]  T. Mulhern,et al.  Tyrosine 416 Is Phosphorylated in the Closed, Repressed Conformation of c-Src , 2013, PloS one.

[41]  J. DeFelipe,et al.  The influence of phospho-tau on dendritic spines of cortical pyramidal neurons in patients with Alzheimer’s disease , 2013, Brain : a journal of neurology.

[42]  Mark S. P. Sansom,et al.  Reduced Lateral Mobility of Lipids and Proteins in Crowded Membranes , 2013, PLoS Comput. Biol..

[43]  Nancy T. Malintan,et al.  Myosin VI small insert isoform maintains exocytosis by tethering secretory granules to the cortical actin , 2013, The Journal of cell biology.

[44]  D. Bennett,et al.  The Complex PrPc-Fyn Couples Human Oligomeric Aβ with Pathological Tau Changes in Alzheimer's Disease , 2012, The Journal of Neuroscience.

[45]  A. Vortmeyer,et al.  Alzheimer Amyloid-β Oligomer Bound to Post-Synaptic Prion Protein Activates Fyn to Impair Neurons , 2012, Nature Neuroscience.

[46]  B. Kay,et al.  Isolation of monobodies that bind specifically to the SH3 domain of the Fyn tyrosine protein kinase. , 2012, New biotechnology.

[47]  W. Noble,et al.  Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau , 2011, The FEBS journal.

[48]  Yoshihisa Kubota,et al.  The impacts of geometry and binding on CaMKII diffusion and retention in dendritic spines , 2011, Journal of Computational Neuroscience.

[49]  Jürgen Götz,et al.  Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease , 2011, Nature Reviews Neuroscience.

[50]  K. Ashe,et al.  Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration , 2010, Neuron.

[51]  S. Yen,et al.  Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy , 2010, Neuropathology and applied neurobiology.

[52]  E. Mandelkow,et al.  Fyn-Tau-Amyloid: A Toxic Triad , 2010, Cell.

[53]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[54]  Omer Dushek,et al.  Constitutively Active Lck Kinase in T Cells Drives Antigen Receptor Signal Transduction , 2010, Immunity.

[55]  W. Klein,et al.  Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5 , 2010, Neuron.

[56]  Kousuke Kasahara,et al.  Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain , 2009, Journal of Cell Science.

[57]  M. Zvelebil,et al.  Phosphorylation Regulates Tau Interactions with Src Homology 3 Domains of Phosphatidylinositol 3-Kinase, Phospholipase Cγ1, Grb2, and Src Family Kinases* , 2008, Journal of Biological Chemistry.

[58]  I. Bahar,et al.  Structure and dynamic regulation of Src-family kinases , 2008, Cellular and Molecular Life Sciences.

[59]  W. Miller,et al.  Cooperative activation of Src family kinases by SH3 and SH2 ligands. , 2007, Cancer letters.

[60]  S. Yen,et al.  Disease-related Modifications in Tau Affect the Interaction between Fyn and Tau* , 2005, Journal of Biological Chemistry.

[61]  L. Mucke,et al.  Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.

[62]  D. Lawrence,et al.  Acquisition of Fyn-selective SH3 domain ligands via a combinatorial library strategy. , 2005, Chemistry & biology.

[63]  L. Mucke,et al.  Fyn Kinase Modulates Synaptotoxicity, But Not Aberrant Sprouting, in Human Amyloid Precursor Protein Transgenic Mice , 2004, The Journal of Neuroscience.

[64]  G. V. Van Hoesen,et al.  Phosphorylation of Tau by Fyn: Implications for Alzheimer's Disease , 2004, The Journal of Neuroscience.

[65]  P. Cohen,et al.  The specificities of protein kinase inhibitors: an update. , 2003, The Biochemical journal.

[66]  M. Vitek,et al.  Tau is essential to β-amyloid-induced neurotoxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[67]  R. Nitsch,et al.  Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.

[68]  Giulio Superti-Furga,et al.  Dynamic Coupling between the SH2 and SH3 Domains of c-Src and Hck Underlies Their Inactivation by C-Terminal Tyrosine Phosphorylation , 2001, Cell.

[69]  Shoji Komai,et al.  Characterization of Fyn-mediated Tyrosine Phosphorylation Sites on GluRε2 (NR2B) Subunit of theN-Methyl-d-aspartate Receptor* , 2001, The Journal of Biological Chemistry.

[70]  L. Toledo,et al.  Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors. , 2000, Structure.

[71]  T. Smithgall,et al.  SH2-Kinase Linker Mutations Release Hck Tyrosine Kinase and Transforming Activities in Rat-2 Fibroblasts* , 1999, The Journal of Biological Chemistry.

[72]  S. Nakanishi,et al.  PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[73]  H. Band,et al.  Tau interacts with src-family non-receptor tyrosine kinases. , 1998, Journal of cell science.

[74]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[75]  D. Bredt,et al.  N-Terminal Palmitoylation of PSD-95 Regulates Association with Cell Membranes and Interaction with K+ Channel Kv1.4 , 1998, Neuron.

[76]  J. Kuriyan,et al.  Structures of Src-family tyrosine kinases. , 1997, Current opinion in structural biology.

[77]  I D Campbell,et al.  Solution structure and peptide binding of the SH3 domain from human Fyn. , 1996, Structure.

[78]  J. Hanke,et al.  Role of tyrosine kinases in lymphocyte activation: Targets for drug intervention , 1995, Inflammation Research.

[79]  R. Pepperkok,et al.  The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[80]  E. Kandel,et al.  Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. , 1992, Science.

[81]  Jürgen Götz,et al.  Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies , 2018, Nature Reviews Neurology.

[82]  J. DeFelipe,et al.  Abnormal tau phosphorylation in the thorny excrescences of CA3 hippocampal neurons in patients with Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[83]  M. Vitek,et al.  Tau is essential to beta -amyloid-induced neurotoxicity. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[84]  S. Komai,et al.  Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor. , 2001, The Journal of biological chemistry.

[85]  S. Courtneidge,et al.  Association of Fyn with the activated platelet-derived growth factor receptor: requirements for binding and phosphorylation. , 1992, Oncogene.